SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-040859
Filing Date
2023-11-14
Accepted
2023-11-14 11:43:56
Documents
47
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 635934
2 ex31-1.htm EX-31.1 18127
3 ex31-2.htm EX-31.2 18130
4 ex32-1.htm EX-32.1 7059
5 ex32-2.htm EX-32.2 7332
  Complete submission text file 0001493152-23-040859.txt   3181659

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE btax-20230930.xsd EX-101.SCH 29288
7 XBRL CALCULATION FILE btax-20230930_cal.xml EX-101.CAL 34336
8 XBRL DEFINITION FILE btax-20230930_def.xml EX-101.DEF 96588
9 XBRL LABEL FILE btax-20230930_lab.xml EX-101.LAB 216052
10 XBRL PRESENTATION FILE btax-20230930_pre.xml EX-101.PRE 164332
41 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 400015
Mailing Address 2431 ALOMA AVE #124 WINTER PARK FL 32792
Business Address 2431 ALOMA AVE #124 WINTER PARK FL 32792 (888) 613-8802
Biostax Corp. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54933 | Film No.: 231402878
SIC: 2834 Pharmaceutical Preparations